Antares Pharma Reports Second Quarter 2015 Operating and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Antares Pharma (ATRS) Tops Q2 EPS by 2c
August 10, 2015 7:31 AM EDTAntares Pharma (NASDAQ: ATRS) reported Q2 EPS of ($0.01), $0.02 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $14.4 million versus the consensus estimate of $10.93 million.
For earnings history and earnings-related data on Antares Pharma (ATRS) click here.
... More